loading
전일 마감가:
$4.43
열려 있는:
$4.45
하루 거래량:
461.29K
Relative Volume:
0.16
시가총액:
$56.95M
수익:
-
순이익/손실:
$-30.54M
주가수익비율:
-2.9032
EPS:
-1.55
순현금흐름:
$-18.30M
1주 성능:
-8.20%
1개월 성능:
-29.34%
6개월 성능:
+585.33%
1년 성능:
+1,020%
1일 변동 폭
Value
$4.38
$4.64
1주일 범위
Value
$4.38
$4.96
52주 변동 폭
Value
$0.202
$8.2457

Unicycive Therapeutics Inc Stock (UNCY) Company Profile

Name
명칭
Unicycive Therapeutics Inc
Name
전화
650-384-0642
Name
주소
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Name
직원
22
Name
트위터
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
UNCY's Discussions on Twitter

UNCY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
UNCY
Unicycive Therapeutics Inc
4.505 62.31M 0 -30.54M -18.30M -1.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.08 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
546.13 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.49 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.22 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.77 27.29B 3.81B -644.79M -669.77M -6.24

Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-21 개시 Guggenheim Buy
2024-04-04 개시 Piper Sandler Overweight

Unicycive Therapeutics Inc 주식(UNCY)의 최신 뉴스

pulisher
02:13 AM

Bronstein, Gewirtz & Grossman, LLC Encourages Unicycive Therapeutics, Inc. (UNCY) Investors to Inquire about Securities Investigation - ACCESS Newswire

02:13 AM
pulisher
Jul 20, 2025

Is Unicycive Therapeutics Inc. a good long term investmentPhenomenal capital appreciation - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

Best Stocks for a Post COVID Recovery in India Financial Expert RecommendationsFree Stock Market Trend Analysis - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about Palladyne AI Corp. stockRapid growth trajectories - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Unicycive Therapeutics Inc. Stock Analysis and ForecastPhenomenal trading returns - Autocar Professional

Jul 19, 2025
pulisher
Jul 19, 2025

EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Jul 19, 2025
pulisher
Jul 19, 2025

ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Jul 19, 2025
pulisher
Jul 19, 2025

UNCY Investors Have Opportunity to Join Unicycive Therapeutics, Inc. Fraud Investigation With the Schall Law Firm - Business Wire

Jul 19, 2025
pulisher
Jul 19, 2025

What analysts say about Unicycive Therapeutics Inc. stockFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Unicycive Therapeutics Inc. stock priceExtraordinary earning power - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-18 04:29:16 - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Why Unicycive Therapeutics Inc. stock is on top investor watchlistsDaily Top Gainers - Newser

Jul 17, 2025
pulisher
Jul 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc.UNCY - PR Newswire

Jul 17, 2025
pulisher
Jul 15, 2025

Why Unicycive Therapeutics Inc. stock attracts strong analyst attentionFast Moving Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Unicycive Therapeutics Inc. stock performs during market volatilityReal Chart Play - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Unicycive Therapeutics Inc. stock price move sharplyFree Trading Strategy Suggestions - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Transcript : Unicycive Therapeutics, Inc. Presents at H.C. Wainwright 4th Annual Kidney Virtual Conference, Jul-14-2025 11 - MarketScreener

Jul 14, 2025
pulisher
Jul 09, 2025

Unicycive Regains Nasdaq Compliance After Stock Split - The Globe and Mail

Jul 09, 2025
pulisher
Jul 09, 2025

Unicycive regains Nasdaq compliance after reverse stock split By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 08, 2025

Unicycive regains Nasdaq compliance after reverse stock split - Investing.com

Jul 08, 2025
pulisher
Jul 08, 2025

Unicycive Therapeutics Regains Compliance with Nasdaq Listing Standards Following Share Price Recovery - Quiver Quantitative

Jul 08, 2025
pulisher
Jul 08, 2025

Unicycive Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire

Jul 08, 2025
pulisher
Jul 08, 2025

Unicycive Successfully Maintains Nasdaq Listing Following 1:10 Reverse Stock Split - Stock Titan

Jul 08, 2025
pulisher
Jul 08, 2025

Unicycive Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference - GlobeNewswire

Jul 08, 2025
pulisher
Jul 08, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Trading 2% Higher – Time to Buy? - Defense World

Jul 08, 2025
pulisher
Jul 07, 2025

Unicycive Therapeutics to Participate in H.C. Wainwright 4th Annual Kidney Virtual Conference - Nasdaq

Jul 07, 2025
pulisher
Jul 07, 2025

Clinical-Stage Kidney Disease Biotech Unicycive Reveals Latest Therapeutic Progress at Major Healthcare Conference - Stock Titan

Jul 07, 2025
pulisher
Jul 03, 2025

Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire

Jul 03, 2025
pulisher
Jul 02, 2025

Unicycive Therapeutics - The Pharma Letter

Jul 02, 2025
pulisher
Jul 02, 2025

Unicycive Shares Sink After FDA Issues Response Letter on Kidney Drug Filing - MSN

Jul 02, 2025
pulisher
Jul 02, 2025

Ongoing Unicycive Therapeutics, Inc. (UNCY) Investigation: Protect Your RightsContact Levi & Korsinsky - ACCESS Newswire

Jul 02, 2025
pulisher
Jul 02, 2025

Ongoing Securities Investigation Into Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky - ACCESS Newswire

Jul 02, 2025
pulisher
Jul 01, 2025

Unicycive stock falls as FDA plans complete response letter for OLC - Investing.com India

Jul 01, 2025
pulisher
Jun 30, 2025

Kaplan Fox & Kilsheimer LLP is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations - FinancialContent

Jun 30, 2025
pulisher
Jun 30, 2025

H.C. Wainwright keeps Buy on Unicycive Therapeutics , says CRL ‘anticipated’ - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

Unicycive stock falls after FDA issues Complete Response Letter By Investing.com - Investing.com Nigeria

Jun 30, 2025
pulisher
Jun 30, 2025

Unicycive stock falls after FDA issues Complete Response Letter - Investing.com Australia

Jun 30, 2025
pulisher
Jun 27, 2025

Pre-market Movers: BBLG, INMB, NAOV, AEMD... - RTTNews

Jun 27, 2025
pulisher
Jun 23, 2025

Does Unicycive Therapeutics Inc (NASDAQ: UNCY) Still Need To Convince Analysts? - Stocksregister

Jun 23, 2025
pulisher
Jun 22, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Shares Gap Down – What’s Next? - Defense World

Jun 22, 2025
pulisher
Jun 18, 2025

Unicycive Therapeutics to execute 1-for-10 reverse stock split - MSN

Jun 18, 2025
pulisher
Jun 17, 2025

Unicycive to implement 1-for-10 reverse stock split to regain Nasdaq listing By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Unicycive Therapeutics to Implement 1-for-10 Reverse Stock Split - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Unicycive Therapeutics (UNCY) Announces 1-for-10 Reverse Stock S - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Unicycive to implement 1-for-10 reverse stock split to regain Nasdaq listing - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Unicycive Therapeutics Announces Reverse Stock Split - marketscreener.com

Jun 17, 2025

Unicycive Therapeutics Inc (UNCY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.67
price down icon 1.03%
$35.60
price up icon 0.17%
$102.58
price down icon 0.03%
$26.88
price up icon 1.05%
$110.44
price down icon 0.20%
biotechnology ONC
$290.46
price down icon 1.81%
자본화:     |  볼륨(24시간):